Athersys
ATHX
#10565
Rank
โ‚น74.85 M
Marketcap
โ‚น1.21
Share price
-33.50%
Change (1 day)
-98.84%
Change (1 year)

Revenue for Athersys (ATHX)

Revenue in 2023 (TTM): โ‚น6.58 Million

According to Athersys's latest financial reports the company's current revenue (TTM ) is โ‚น7.18 Million. In 2022 the company made a revenue of โ‚น0.44 Billion an increase over the revenue in the year 2021 that were of โ‚น0.41 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Athersys from 2007 to 2023

Annual revenue

Year Revenue Change
2023 (TTM) โ‚น6.58 M-98.51%
2022 โ‚น0.44 B7.35%
2021 โ‚น0.41 B291.89%
2020 โ‚น0.10 B-73.38%
2019 โ‚น0.39 B-76.3%
2018 โ‚น1.65 B814.32%
2017 โ‚น0.18 B-83.55%
2016 โ‚น1.10 B61.24%
2015 โ‚น0.68 B3675.51%
2014 โ‚น18.12 M-61.14%
2013 โ‚น46.64 M-86.51%
2012 โ‚น0.34 B-36.79%
2011 โ‚น0.54 B36.61%
2010 โ‚น0.40 B299.85%
2009 โ‚น0.10 B-32.88%
2008 โ‚น0.14 B16.65%
2007 โ‚น0.12 B

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Amgen
AMGN
โ‚น3.231 T 44,963,650.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
โ‚น5.640 T 78,482,400.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
โ‚น4.315 T 60,042,400.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Moderna
MRNA
โ‚น197.81 B 2,752,400.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
โ‚น8.278 T 115,186,150.00%๐Ÿ‡บ๐Ÿ‡ธ USA
United States Lime & Minerals
USLM
โ‚น32.77 B 455,961.25%๐Ÿ‡บ๐Ÿ‡ธ USA
Arena Pharmaceuticals
ARNA
โ‚น33.5 M 366.25%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
โ‚น5.770 T 80,293,650.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
โ‚น4.269 T 59,406,251.25%๐Ÿ‡ซ๐Ÿ‡ท France